Exhibition Debut
Found Diagrams and Simulations of Supply Chains
Apple’s Supply Chain, image by Supply Chain 247
Screenshot from Siemens Process Simulate by Siemens and ArtiMinds Robotics
Screenshot from FlexSim visualisation of logistical process
Image of robot arm and virtual robot arm from Siemens Tecnomatix
Screenshot from Tecnomatix Plant Simulation Software by Siemens
Screenshot from Tecnomatix Plant Simulation Software by Siemens
Screenshot from SimCAD Pro by CreateASoft
Found Diagrams of Pharmaceutical Supply Chain
Pharmaceutical purchasing matrix, image by Garlapati and Sewoyo
Model for central storage for critical drugs, image by Garlapati and Sewoyo
Delivery pipeline for Rifampicin in Sweden, image by Garlapati and Sewoyo
Reasons for drug shortages in the U.S. 2013, image by Garlapati and Sewoyo
Definition of supply functions in supply chain management, image by Garlapati and Sewoyo
Overview of sourcing options for Rifampicin and Benzylpenicillin, image by Garlapati and Sewoyo
Reference process for purchasing, image by Garlapati and Sewoyo
Schematic overview of pharmaceutical supply chain, image by Garlapati and Sewoyo
Supply chain sourcing, image by Garlapati and Sewoyo
Zeton modular process production plant
Soundscape and Scenario Diagrams
Found Images of Visual Sound
Automated Guided Pallet Machines
Capsules In The Containers
Closed Pills Into Folded Boxes
Conveyor Belt
Grouping Of Packages Lifted Together On Another Conveyor
On Its Way To The Warehouse
Packed Pressing Machines
Paper Flipping Fast
Paper Flipping Fast 2
Pill Compressor Very Fast
Pill Compressor Very Fast 2
Pills Being Turned Around And Spun With Coating
Powder Pushed Out Of Mixer
Robot Arms Putting Together Boxes
Spray Film On Top Of Pill
Tablet Slides Down After Compressor
Unfolding Paper Into Boxes
Film Storyboards
Stills from Draft Rendering
Stills from Mutated Industry Final Film
Mutated Industry
Lauriane Heim and Colette Aliman
COVID-19 is marking a re-structuring of the pharmaceutical landscape as nation states recognize a need for security and resilience within production processes. Heavily affected by the pandemic, the production of paracetamol slowed down significantly while demands grew due to the medication’s positive impact on symptoms of an infection with COVID-19.
In response to the ongoing global pandemic, Mutated Industry points out how a highly confidential and ingrained pharmaceutical industry is developing resilient approaches to redesign its global supply chain. With a scenario set three years in the future, Mutated Industry explores strategies of total reshoring, the return of production back to the company’s original country, of a component critical for pharmaceutical production. A symphonic visual lecture, Mutated Industry addresses possible developments within a global pharmaceutical supply chain incited by disruptions caused by COVID-19.
Credits
Script: Colette Aliman, Lauriane Heim, Dr. Yao Jin
3D Rendering: Colette Aliman, Lauriane Heim, Alexandre Harster
Sound: Colette Aliman, Lauriane Heim, Guillaume Reibel, Johan Viladrich and Vincent Picoteiro
Additional Material
Mutated Industry Film Script PDF Link
References
Alan Rooks, “COVID-19’s Impact on Reshoring and the Supply Chain,” SME, April 21, 2020. Link
AstraZeneca Sverige, “How medicines are made,” YouTube, August 18, 2016. Link
Dalia Marin, “How COVID-19 Is Transforming Manufacturing,” Project Syndicate, April 3, 2020. Link
Emily Arntsen, “The Global Medical Supply Chain Is Not Immune To Covid-19,” News @ Northeastern, March 16, 2020. Link
“European Online Pharmacy Market Insights, 2020-2025: COVID-19 Impact Assessment - ResearchAndMarkets.com,” Business Wire, April 14, 2020. Link
George Underwood, “Antibiotic Supply Chains on ‘Brink of Collapse,’” Pharma Times, May 31, 2018. Link
Hannah Balfour, “COVID-19 update: coronavirus and the pharmaceutical supply chain,” European Pharmaceutical Review, April 1, 2020. Link
Joanna York, “Paracetamol to Be Made in France Post Covid-19,” Connexion France, September 26, 2020. Link
Jonty Bloom, “Will Coronavirus Reverse Globalisation?” BBC News, April 1, 2020. Link
Keith B. Belton, “COVID-19 Makes the Case for Resilient Manufacturing,” Industry Week, April 20, 2020. Link
Pierre Fabre Group, “Pharmaceutical production site of Gien,” YouTube, August 6, 2014. Link
Raja Mohan, “Coronavirus Outbreak Highlights China’s Dominance over Pharmaceutical Industry,” The Indian Express, March 10, 2020. Link
“Reshaping Global Value: Technology, Climate, Trade – Global Value Chains under Pressure,” World Economic Forum, September 26, 2020. Link
“Reshoring the health industries in Europe,” Gouvernement, June 18, 2020. Link
Rick Mullin, “COVID-19 is reshaping the pharmaceutical supply chain,” C&EN , April 27, 2020. Link
Seric Adnan and Deborah Winkler, “COVID-19 Could Spur Automation and Reverse Globalisation – to Some Extent,” VoxEU, April 28 2020. Link
Shailesh Garlapati and Vinana Sewoyo, "Improving Antibiotic Availability by Restructuring the Supply Chain: A Case Study Within Sweden" (Master's thesis, Uppsala Universitet, 2019). Link
Susan Helper, “How COVID-19 makes the case for ‘high-road’ supply chains,” SupplyChainDive, April 22, 2020. Link
Taylor Peter, “World-Systems Analysis and Globalization. A Jacobsean Exploration of Pasts, Presents and Futures,” Belgeo 3 (2005): 265–274. Link
Uma S. Kambhampati, “The Whole Idea of Global Value Chains Will Be Reconsidered after Coronavirus,” The Conversation, September 26, 2020. Link
Yao Jin and Lisa Ellram, “To prepare for the next ‘black swan’ event, supply chains should rethink ‘lean,’” SupplyChainDive, April 14, 2020. Link
Bio
Colette Aliman (MA Contextual Design, 2019) and Lauriane Heim (MA Social Design, 2019) fabricate a future scenario in their project Mutated Industry, which explores a Eurocentric approach to the redevelopment of the French paracetamol supply chain.